BIOMERICA INC. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Stockholders held by Biomerica, Inc. on December 12, 2025. The record date for the meeting was October 15, 2025, with 2,947,966 shares of common stock outstanding and entitled to vote. A total of 1,554,917 shares were present in person or by proxy, establishing a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders voted on six proposals. The results are summarized below:
- Proposal 1 (Election of Directors): All five nominees (Zackary Irani, Allen Barbieri, Eric Bing Chin, Gary Huff, David Moatazedi) were elected. Broker non-votes totaled 1,048,958 for each nominee.
- Proposal 2 (Executive Compensation): Approved on a non-binding advisory basis with 411,157 votes for and 87,344 votes against.
- Proposal 3 (Auditor Ratification): Ratified Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2026. Received 1,472,716 votes for and 73,443 votes against.
- Proposal 4 (Stock Incentive Plan Amendment): Approved an increase of 200,000 shares authorized for issuance under the 2024 Stock Incentive Plan. Received 371,339 votes for and 131,430 votes against.
- Proposal 5 (Authorized Share Increase): Approved an amendment to the Certificate of Incorporation to increase authorized common stock from 25,000,000 to 300,000,000 shares. Received 1,028,102 votes for and 513,650 votes against.
- Proposal 6 (Adjournment): Approved the ability to adjourn the meeting if necessary. Received 1,349,014 votes for and 187,592 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verification of the significant increase in authorized shares from 25 million to 300 million, which may impact dilution potential.
- Confirmation of the high number of broker non-votes (1,048,958) on director elections and executive compensation, indicating a large portion of shares held by brokers without voting instructions.
- Review of the specific terms of the 200,000 share increase to the 2024 Stock Incentive Plan.
- Confirmation that the auditor ratification covers the fiscal year ending May 31, 2026.